Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
Topics Covered
- Introduction to pharmacology
- Introduction to pharmacokinetics
- Introduction to routes of administration
- Introduction to drug formulations
- Introduction to PK/PD integration
- Introduction to pharmacogenetics
- Introduction to drug toxicity
Talk Citation
Allegaert, K. (2024, October 31). An introduction to general clinical pharmacology [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 13, 2024, from https://doi.org/10.69645/RQTV3300.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose. However, off label use of medicines is discussed.
Other Talks in the Series: Key Concepts: Fundamentals of Pharmacology
Transcript
Please wait while the transcript is being prepared...
0:00
Welcome to this
introductory talk
on general pharmacology.
I'm Karel Allegaert.
I'm a clinical pharmacologist
located at KU Leuven,
which is in Belgium,
as well as in Erasmus
Medical Center,
which is in the Netherlands.
0:18
Why are we covering this topic?
Simply because drugs are
a crucial part of proven,
effective interventions to
improve patient health outcomes
and healthcare efficiency,
while individual responses
to medicine may vary,
related to medicine and
patient-specific characteristics.
That's all about PK and PD.
From a health equity
point of view
and an outcome-relevant
disease point of view,
I can only provide
you some examples,
like, for instance, the
recent COVID vaccinations,
treatments for acute leukemia,
or novel treatments for
spinal muscular atrophy
or cystic fibrosis,
to illustrate the impact
of effective pharmacological
interventions.
1:06
What will we cover
in these lectures?
Well, we will cover,
obviously, pharmacokinetics,
and because of the volume,
we have split this
up into two parts.
The first part is
focusing on absorption,
bioavailability,
and distribution,
while the second part has
its focus on metabolism,
excretion, and the
therapeutic window.
We will discuss routes
of administration,
drug formulation,
pharmacokinetic and
pharmacodynamic integration,
and then a specific focus
on pharmacogenetics
and drug toxicity,
including some
mechanisms, interactions,
and adverse drug reactions.
In the pharmacokinetics,